219 related articles for article (PubMed ID: 22736108)
1. Role of NQO1 609C>T and NQO2 -3423G>A gene polymorphisms in esophageal cancer risk in Kashmir valley and meta analysis.
Malik MA; Zargar SA; Mittal B
Mol Biol Rep; 2012 Sep; 39(9):9095-104. PubMed ID: 22736108
[TBL] [Abstract][Full Text] [Related]
2. Null association of NQO1 609C>T and NQO2 -3423G>A polymorphisms with susceptibility and prognosis of Esophageal cancer in north Indian population and meta-analysis.
Umar M; Upadhyay R; Kumar S; Ghoshal UC; Mittal B
Cancer Epidemiol; 2012 Dec; 36(6):e373-9. PubMed ID: 22770696
[TBL] [Abstract][Full Text] [Related]
3. Role of NQO1 609C>T and NQO2-3423G>A polymorphisms in susceptibility to gastric cancer in Kashmir valley.
Malik MA; Zargar SA; Mittal B
DNA Cell Biol; 2011 May; 30(5):297-303. PubMed ID: 21294640
[TBL] [Abstract][Full Text] [Related]
4. Genetic variants in metabolizing genes NQO1, NQO2, MTHFR and risk of prostate cancer: a study from North India.
Mandal RK; Nissar K; Mittal RD
Mol Biol Rep; 2012 Dec; 39(12):11145-52. PubMed ID: 23054000
[TBL] [Abstract][Full Text] [Related]
5. Association of NQO1 levels and its genetic polymorphism with susceptibility to methamphetamine dependence.
Liu H; Zhang W; Deng XD; Ma Y; Liu Y
Mol Genet Genomic Med; 2021 Oct; 9(10):e1789. PubMed ID: 34467676
[TBL] [Abstract][Full Text] [Related]
6. Association of NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism with esophageal squamous cell carcinoma in a German Caucasian and a northern Chinese population.
Zhang J; Schulz WA; Li Y; Wang R; Zotz R; Wen D; Siegel D; Ross D; Gabbert HE; Sarbia M
Carcinogenesis; 2003 May; 24(5):905-9. PubMed ID: 12771035
[TBL] [Abstract][Full Text] [Related]
7. NAD(P)H:quinone oxidoreductase 1 and nrh:quinone oxidoreductase 2 activity and expression in bladder and ovarian cancer and lower NRH:quinone oxidoreductase 2 activity associated with an NQO2 exon 3 single-nucleotide polymorphism.
Jamieson D; Wilson K; Pridgeon S; Margetts JP; Edmondson RJ; Leung HY; Knox R; Boddy AV
Clin Cancer Res; 2007 Mar; 13(5):1584-90. PubMed ID: 17332305
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis of the NAD(P)H: quinine oxidoreductase 1 gene 609 C>T polymorphism with esophageal cancer risk.
Wang Z; Hu J; Zhong J
DNA Cell Biol; 2012 Apr; 31(4):560-7. PubMed ID: 22017531
[TBL] [Abstract][Full Text] [Related]
9. NQO1 609C>T polymorphism interaction with tobacco smoking and alcohol drinking increases colorectal cancer risk in a Chinese population.
Peng XE; Jiang YY; Shi XS; Hu ZJ
Gene; 2013 May; 521(1):105-10. PubMed ID: 23458878
[TBL] [Abstract][Full Text] [Related]
10. Association analyses between polymorphisms of the phase II detoxification enzymes (GSTM1, NQO1, NQO2) and alcohol withdrawal symptoms.
Okubo T; Harada S; Higuchi S; Matsushita S
Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):68S-71S. PubMed ID: 12960511
[TBL] [Abstract][Full Text] [Related]
11. No associations between Parkinson's disease and polymorphisms of the quinone oxidoreductase (NQO1, NQO2) genes.
Okada S; Farin FM; Stapleton P; Viernes H; Quigley SD; Powers KM; Smith-Weller T; Franklin GM; Longstreth WT; Swanson PD; Checkoway H
Neurosci Lett; 2005 Mar; 375(3):178-80. PubMed ID: 15694256
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphism 609C>T in NAD(P)H:quinone oxidoreductase 1 enhances the risk of proximal colon cancer.
Freriksen JJ; Salomon J; Roelofs HM; Te Morsche RH; van der Stappen JW; Dura P; Witteman BJ; Lacko M; Peters WH
J Hum Genet; 2014 Jul; 59(7):381-6. PubMed ID: 24830960
[TBL] [Abstract][Full Text] [Related]
13. NQO1 rs1800566 C>T polymorphism was associated with a decreased risk of esophageal cancer in a Chinese population.
Yin J; Wang L; Wang X; Zheng L; Shi Y; Shao A; Tang W; Ding G; Liu C; Liu R; Chen S; Gu H
Scand J Gastroenterol; 2014 Mar; 49(3):317-22. PubMed ID: 24354914
[TBL] [Abstract][Full Text] [Related]
14. NQO1 C609T polymorphism is associated with esophageal cancer risk among Chinese: a meta-analysis.
Zhao HY; Gu Y; Yi YX
Tumour Biol; 2014 Mar; 35(3):2199-203. PubMed ID: 24142529
[TBL] [Abstract][Full Text] [Related]
15. Association between NQO1 Pro187Ser polymorphism and esophageal cancer: a meta-analysis.
Liu K; Tian H; Yu KZ; Shen WY; Mao ZC; Jin CH; Pan HB; He JX
Tumour Biol; 2014 Mar; 35(3):2063-8. PubMed ID: 24213850
[TBL] [Abstract][Full Text] [Related]
16. Nucleotide and deduced amino acid sequence of a human cDNA (NQO2) corresponding to a second member of the NAD(P)H:quinone oxidoreductase gene family. Extensive polymorphism at the NQO2 gene locus on chromosome 6.
Jaiswal AK; Burnett P; Adesnik M; McBride OW
Biochemistry; 1990 Feb; 29(7):1899-906. PubMed ID: 1691923
[TBL] [Abstract][Full Text] [Related]
17. NAD(P)H: quinone oxidoreductase 1 and NRH:quinone oxidoreductase 2 polymorphisms in papillary thyroid microcarcinoma: correlation with phenotype.
Lee J; Kim KS; Lee MH; Kim YS; Lee MH; Lee SE; Kim YK; Ryu MJ; Kim SJ; Choi MJ; Jo YS
Yonsei Med J; 2013 Sep; 54(5):1158-67. PubMed ID: 23918565
[TBL] [Abstract][Full Text] [Related]
18. Association between NAD(P)H: quinone oxidoreductase 1 (NQ01) inactivating C609T polymorphism and adenocarcinoma of the upper gastrointestinal tract.
Sarbia M; Bitzer M; Siegel D; Ross D; Schulz WA; Zotz RB; Kiel S; Geddert H; Kandemir Y; Walter A; Willers R; Gabbert HE
Int J Cancer; 2003 Nov; 107(3):381-6. PubMed ID: 14506737
[TBL] [Abstract][Full Text] [Related]
19. A functional NQO1 609C>T polymorphism and risk of hepatocellular carcinoma in a Chinese population.
Liu F; Luo L; Wei Y; Wang W; Li B; Yan L; Wen T
Tumour Biol; 2013 Feb; 34(1):47-53. PubMed ID: 22972504
[TBL] [Abstract][Full Text] [Related]
20. The NAD(P)H: quinine oxidoreductase 1 (NQO1) gene 609 C>T polymorphism is associated with gastric cancer risk: evidence from a case-control study and a meta-analysis.
Hu WG; Hu JJ; Cai W; Zheng MH; Zang L; Wang ZT; Zhu ZG
Asian Pac J Cancer Prev; 2014; 15(5):2363-7. PubMed ID: 24716985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
